Skip To Content

Franken Proves a Formidable Foe

If Republican Senator Norm Coleman fails to win his 2008 re-election bid in Minnesota, it seems increasingly likely it will go to another Jewish American: former “Saturday Night Live” comedian Al Franken.

Franken, the humorist turned liberal pundit, could become the fourth Jewish politician in a row to occupy the Coleman Senate seat. Since 1979, the seat has been held by Republican Rudy Boschwitz, followed by liberal Democrat Paul Wellstone and then Coleman.

Franken edged out Coleman 49% to 46% in a telephone survey conducted by independent polling firm Rasmussen Reports on February 16. The results showed significant gains for Franken, who trailed Coleman by 7 percentage points early last November, according to a similar poll conducted by Rasmussen. The margin of error for both polls was 4.5%.

For now, Franken is working to secure the Democratic nomination, and hoping to best several contenders — including his lead rival, trial attorney Mike Ciresi — at the party’s endorsement convention in June. Franken is significantly ahead in the money race, with $7.2 million raised in 2007 compared with Ciresi’s haul of $1.9 million, and has won a number of key backers, including the Service Employees International Union, which announced its endorsement February 26. One day earlier, Ciresi’s campaign announced that the attorney had recently loaned it $2 million.

Franken has led the Democratic field in recent polling — he held a wide margin over Ciresi, 32% to 17%, in a survey conducted in early February by Minnesota Public Radio and the Humphrey Institute of Public Affairs — but the race could prove unpredictable, because of Minnesota’s arcane primary process. While the official primary for the Democrats, known as the Minnesota Democrat-Farmer-Labor Party, will be held in September, 1,400 party delegates will issue an official endorsement at a state convention held in June. By tradition, the endorsement is seen as binding, and both Franken and Ciresi have vowed to withdraw from the race without it.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.